These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 2229523)
1. Pharmacology of the allylamines. Birnbaum JE J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):782-5. PubMed ID: 2229523 [TBL] [Abstract][Full Text] [Related]
2. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Petranyi G; Ryder NS; Stütz A Science; 1984 Jun; 224(4654):1239-41. PubMed ID: 6547247 [TBL] [Abstract][Full Text] [Related]
3. Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes. Vago T; Baldi G; Colombo D; Barbareschi M; Norbiato G; Dallegri F; Bevilacqua M Antimicrob Agents Chemother; 1994 Nov; 38(11):2605-11. PubMed ID: 7872755 [TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent. Ryder NS Antimicrob Agents Chemother; 1985 Feb; 27(2):252-6. PubMed ID: 4039119 [TBL] [Abstract][Full Text] [Related]
5. Antimycotic susceptibility testing of mould-fungi with allylamines by disk diffusion. Venugopal PV; Venugopal TV Indian J Med Sci; 1995 May; 49(5):109-13. PubMed ID: 8772831 [TBL] [Abstract][Full Text] [Related]
6. Differential inhibition of fungal amd mammalian squalene epoxidases by the benzylamine SDZ SBA 586 in comparison with the allylamine terbinafine. Favre B; Ryder NS Arch Biochem Biophys; 1997 Apr; 340(2):265-9. PubMed ID: 9143330 [TBL] [Abstract][Full Text] [Related]
7. Allylamine antifungal drugs. Ryder NS; Mieth H Curr Top Med Mycol; 1992; 4():158-88. PubMed ID: 1732066 [No Abstract] [Full Text] [Related]
8. Disk diffusion susceptibility testing of dermatophytes with allylamines. Venugopal PV; Venugopal TV Int J Dermatol; 1994 Oct; 33(10):730-2. PubMed ID: 8002146 [TBL] [Abstract][Full Text] [Related]
9. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Ryder NS Br J Dermatol; 1992 Feb; 126 Suppl 39():2-7. PubMed ID: 1543672 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of action and biochemical selectivity of allylamine antimycotic agents. Ryder NS Ann N Y Acad Sci; 1988; 544():208-20. PubMed ID: 3063168 [No Abstract] [Full Text] [Related]
11. Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes. Ryder NS; Dupont MC Biochem J; 1985 Sep; 230(3):765-70. PubMed ID: 3877503 [TBL] [Abstract][Full Text] [Related]
12. Terbinafine: a review of its use in onychomycosis in adults. Darkes MJ; Scott LJ; Goa KL Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372 [TBL] [Abstract][Full Text] [Related]
13. The mode of antifungal action of tolnaftate. Barrett-Bee KJ; Lane AC; Turner RW J Med Vet Mycol; 1986 Apr; 24(2):155-60. PubMed ID: 3522841 [TBL] [Abstract][Full Text] [Related]
14. Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents. Favre B; Ryder NS Antimicrob Agents Chemother; 1996 Feb; 40(2):443-7. PubMed ID: 8834895 [TBL] [Abstract][Full Text] [Related]
15. In-vitro studies with SF 86-327, a new orally active allylamine derivative. Shadomy S; Espinel-Ingroff A; Gebhart RJ Sabouraudia; 1985 Apr; 23(2):125-32. PubMed ID: 2990057 [TBL] [Abstract][Full Text] [Related]
16. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis. Del Rosso JQ; Kircik LH J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340 [TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of allylamines on Epidermophyton floccosum: scanning electron microscopy study. Butty P; Mallié M; Bastide JM Mycopathologia; 1992 Dec; 120(3):147-53. PubMed ID: 1494360 [TBL] [Abstract][Full Text] [Related]
18. Terbinafine. An update of its use in superficial mycoses. McClellan KJ; Wiseman LR; Markham A Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936 [TBL] [Abstract][Full Text] [Related]
19. Oral terbinafine: a new antifungal agent. Abdel-Rahman SM; Nahata MC Ann Pharmacother; 1997 Apr; 31(4):445-56. PubMed ID: 9101008 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacology of terbinafine and itraconazole. Leyden J J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S42-7. PubMed ID: 9594936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]